Related transcriptional enhancer factor 1 increases endothelial-dependent microvascular relaxation and proliferation

Journal of Vascular Research

Volumn 49, Issue 3, 2012, Pages 249-259

  Messmer Blust, Angela F ^a   Zhang, Cuili ^a,c   Shie, Jue Lon ^a   Song, Qinhui ^a   He, Ping ^a   Lubenec, Isabel ^a   Liu, Yuhong ^b   Sellke, Frank ^b   Li, Jian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial function; Endothelial nitric oxide synthase; Fibroblast growth factor receptor 1; Microvascular relaxation; Related transcriptional enhancer factor 1

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; RELATED TRANSCRIPTIONAL ENHANCER FACTOR 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VASCULAR DISEASE; VASODILATATION;

ANIMALS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; HUMANS; MICROVESSELS; MUSCLE PROTEINS; NITRIC OXIDE SYNTHASE TYPE III; PROMOTER REGIONS, GENETIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VASODILATION;

EID: 84862803327     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000335180     Document Type: Article

References (25)

1. Poole TJ, Finkelstein EB, Cox CM: The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 2001; 220: 1-17. (Pubitemid 32049454)
2. Kuo L, Chilian WM, Davis MJ, Laughlin MH: Endotoxin impairs flow-induced vasodilation of porcine coronary arterioles. Am J Physiol 1992; 262:H1838-H1845.
3. Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, Li J, Simons M: Enhanced microvascular relaxations to VEGF and BFGF in chronically ischemic porcine myocardium. Am J Physiol 1996; 271:H713-H720.
4. Chen HH, Baty CJ, Maeda T, Brooks S, Baker LC, Ueyama T, Gursoy E, Saba S, Salama G, London B, Stewart AF: Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. Circulation 2004; 110: 2980-2987. (Pubitemid 39491987)
5. Farrance IK, Ordahl CP: The role of transcription enhancer factor-1 (TEF-1) related proteins in the formation of M-CAT binding complexes in muscle and non-muscle tissues. J Biol Chem 1996; 271: 8266-8274. (Pubitemid 26108659)
6. Gan Q, Yoshida T, Li J, Owens GK: Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res 2007; 101: 883-892. (Pubitemid 350287175)
7. Maeda T, Maeda M, Stewart AF: TEF-1 transcription factors regulate activity of the mouse mammary tumor virus LTR. Biochem Biophys Res Commun 2002; 296: 1279-1285.
8. Maeda T, Mazzulli JR, Farrance IK, Stewart AF: Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes. J Biol Chem 2002; 277: 24346-24352. (Pubitemid 34951955)
9. Mahoney WM, Jr, Hong JH, Yaffe MB, Farrance IK: The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 2005; 388: 217-225. (Pubitemid 40732949)
10. Appukuttan B, McFarland TJ, Davies MH, Atchaneeyasakul LO, Zhang Y, Babra B, Pan Y, Rosenbaum JT, Acott T, Powers MR, Stout JT: Identification of novel alternatively spliced isoforms of RTEF-1 within human ocular vascular endothelial cells and murine retina. Invest Ophthalmol Vis Sci 2007; 48: 3775-3782. (Pubitemid 351261117)
11. Shie JL, Wu G, Wu J, Liu FF, Laham RJ, Oettgen P, Li J: RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem 2004; 279: 25010-25016. (Pubitemid 38756749)
12. Xu M, Jin Y, Song Q, Wu J, Philbrick MJ, Cully BL, An X, Guo L, Gao F, Li J: The endothelial-dependent effect of RTEF-1 in pressure overload cardiac hypertrophy-role of VEGF-B. Cardiovasc Res 2011; 90: 325-334.
13. Gory S, Vernet M, Laurent M, Dejana E, Dalmon J, Huber P: The vascular endothelialcadherin promoter directs endothelial-specific expression in transgenic mice. Blood 1999; 93: 184-192. (Pubitemid 29019402)
14. McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA, Gittoes NJ: Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxf) 2003; 58: 141-150. (Pubitemid 36194267)
15. Feng J, Bianchi C, Sandmeyer JL, Sellke FW: Bradykinin preconditioning improves the profile of cell survival proteins and limits apoptosis after cardioplegic arrest. Circulation 2005; 112:I190-I195. (Pubitemid 41266672)
16. Li J, Partovian C, Li J, Hampton TG, Metais C, Tkachenko E, Sellke FW, Simons M: Modulation of microvascular signaling by heparan sulfate matrix: studies in syndecan-4 transgenic mice. Microvasc Res 2002; 64: 38-46. (Pubitemid 34713229)
17. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M: Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 159-178. (Pubitemid 40616114)
18. Boodhwani M, Voisine P, Ruel M, Sodha NR, Feng J, Xu SH, Bianchi C, Sellke FW: Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction. Eur J Cardiothorac Surg 2008; 33: 645-650; discussion 251-642.
19. Simons M, Laham RJ, Post M, Sellke FW: Therapeutic angiogenesis: potential role of basic fibroblast growth factor in patients with severe ischaemic heart disease. Bio-Drugs 2000; 14: 13-20. (Pubitemid 30643207)
20. Ciruna BG, Schwartz L, Harpal K, Yamaguchi TP, Rossant J: Chimeric analysis of fibroblast growth factor receptor-1 (FGFR1) function: A role for FGFR1 in morphogenetic movement through the primitive streak. Development 1997; 124: 2829-2841. (Pubitemid 27354829)
21. Dell'Era P, Ronca R, Coco L, Nicoli S, Metra M, Presta M: Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ Res 2003; 93: 414-420. (Pubitemid 37100006)
22. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM: Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992; 71: 1088-1100.
23. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M: Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987; 84: 2292-2296. (Pubitemid 17075857)
24. Battler A, Scheinowitz M, Bor A, Hasdai D, Vered Z, Di Segni E, Varda-Bloom N, Nass D, Engelberg S, Eldar M, et al: Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 1993; 22: 2001-2006. (Pubitemid 23359664)
25. Srivastava S, Terjung RL, Yang HT: Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2003; 285:H1190-H1197. (Pubitemid 37048176)